Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BSD Medical (Long Term Investment Oriented) -- Ignore unavailable to you. Want to Upgrade?

To: nothingoutofbounds who wrote (106)	2/8/2013 10:09:34 AM
From: pleonastic	1 Recommendation Read Replies (1) \| Respond to of 178

>It looks like this quarter’s numbers will present a more accurate depiction of what is to come as I expect the already expanding % increase to grow even larger and the bottom line numbers should be boosted from other sales and the backlog clearing accounting wise... It would not surprise me if we get some indication of this (ablation system sales % increase) sooner than earnings release as BSD has seemed to begun touting their own performance more effectively with the success of FPU program.< Could happen, I agree. But, BSD M’s sales are still highly variable from Q to Q. What appears reasonably certain is that sales for all of FY 2013 are going to be much higher. I think there is at least one more major U.S. metro area to be added to the FPU program. Right? And, some other metro areas added to the queue? And, will there be distributers other than Appleton who buy MTX-180’s for use in their own FPU programs? Seems likely to me. I look for another CC soon – within a month or so – as much is happening that needs elucidation.